These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29232385)

  • 1. Sustaining visceral leishmaniasis elimination in Bangladesh - Could a policy brief help?
    Fitzpatrick A; Al-Kobaisi NSMS; Beitman Maya J; Ren Chung Y; Duhan S; Elbegdorj E; Jain S; Kuhn E; Nastase A; Ahmed BN; Olliaro P
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006081. PubMed ID: 29232385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.
    Bhandari GP; Angdembe MR; Rijal S; Boelaert M
    Nepal Med Coll J; 2011 Sep; 13(3):220-5. PubMed ID: 22808821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in visceral leishmaniasis control and elimination in the developing countries: A review.
    Hailu T; Yimer M; Mulu W; Abera B
    J Vector Borne Dis; 2016; 53(3):193-8. PubMed ID: 27681541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.
    Le Rutte EA; Chapman LAC; Coffeng LE; Ruiz-Postigo JA; Olliaro PL; Adams ER; Hasker EC; Boelaert MC; Hollingsworth TD; Medley GF; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S301-S308. PubMed ID: 29860292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of visceral leishmaniasis elimination program in India: a picture imperfect.
    Gurunath U; Joshi R; Agrawal A; Shah V
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):929-35. PubMed ID: 24930676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.
    Chowdhury R; Mondal D; Chowdhury V; Faria S; Alvar J; Nabi SG; Boelaert M; Dash AP
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3020. PubMed ID: 25144317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
    Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.
    Joshi AB; Banjara MR; Chuke S; Kroeger A; Jain S; Aseffa A; Reeder JC
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011714. PubMed ID: 37943733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.
    Engwerda CR; Matlashewski G
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):423-4. PubMed ID: 26048873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
    Bern C; Chowdhury R
    Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the natural history of visceral leishmaniasis and consequences for control.
    Chapman LA; Dyson L; Courtenay O; Chowdhury R; Bern C; Medley GF; Hollingsworth TD
    Parasit Vectors; 2015 Oct; 8():521. PubMed ID: 26490668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can visceral leishmaniasis be eliminated from Asia?
    Joshi A; Narain JP; Prasittisuk C; Bhatia R; Hashim G; Jorge A; Banjara M; Kroeger A
    J Vector Borne Dis; 2008 Jun; 45(2):105-11. PubMed ID: 18592839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.
    Sundar S; Mondal D; Rijal S; Bhattacharya S; Ghalib H; Kroeger A; Boelaert M; Desjeux P; Richter-Airijoki H; Harms G
    Trop Med Int Health; 2008 Jan; 13(1):2-5. PubMed ID: 18290995
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral leishmaniasis: elimination with existing interventions.
    Matlashewski G; Arana B; Kroeger A; Battacharya S; Sundar S; Das P; Sinha PK; Rijal S; Mondal D; Zilberstein D; Alvar J
    Lancet Infect Dis; 2011 Apr; 11(4):322-5. PubMed ID: 21453873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the Mathematical Modelling of Visceral Leishmaniasis.
    Rock KS; Quinnell RJ; Medley GF; Courtenay O
    Adv Parasitol; 2016; 94():49-131. PubMed ID: 27756459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of a malaria surveillance system for use in a visceral leishmaniasis elimination programme.
    Foster GM; Dunkley S; Deb RM; Thomsen E; Coleman M; Dhariwal AC; Das Gupta RK; Srikantiah S; Das P; Coleman M
    Int Health; 2017 May; 9(3):195-201. PubMed ID: 28582562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for malaria elimination in Brazil.
    Ferreira MU; Castro MC
    Malar J; 2016 May; 15(1):284. PubMed ID: 27206924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India.
    Le Rutte EA; Coffeng LE; Muñoz J; de Vlas SJ
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):229-235. PubMed ID: 33580952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis control in Thi Qar Governorate, Iraq, 2003.
    Jassim AK; Maktoof R; Ali H; Budosan B; Campbell K
    East Mediterr Health J; 2006; 12 Suppl 2():S230-7. PubMed ID: 17361695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present situation of vector-control management in Bangladesh: a wake up call.
    Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
    Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.